Search results
18 mar 2004 · Antiresorptive agents are widely used to treat osteoporosis. We report the results of a multinational randomized, double-blind study, in which postmenopausal women with osteoporosis were treated...
- Romosozumab or Alendronate for Fracture Prevention in Women with ...
Alendronate is an antiresorptive agent commonly used as...
- Romosozumab or Alendronate for Fracture Prevention in Women with ...
12 mar 2022 · The ARCH study randomly assigned 4093 women to monthly romosozumab or weekly alendronate (70 mg) for 12 months, followed by open-label alendronate alone in both groups.
18 lut 2020 · Consider anabolic therapy (teriparatide or abaloparatide) for women at very high risk of fractures, including those with multiple fractures. All women undergoing treatment with osteoporosis therapies other than anabolic therapy should consume calcium and vitamin D in their diet or via supplements.
Alendronate is used to prevent and treat osteoporosis (thinning of the bone) in women after menopause. This medicine may also be used to increase bone mass in men who have osteoporosis, and in men and women to prevent and treat osteoporosis caused by long-term use of corticosteroids (cortisone-like medicine).
12 paź 2017 · Alendronate is an antiresorptive agent commonly used as first-line therapy for osteoporosis. In a trial involving postmenopausal women with prevalent fractures, the risks of vertebral and...
Alendronate has been shown to increase bone mineral density (BMD) and decrease fracture risk in postmenopausal women with osteoporosis, but the need for long-term treatment is unclear, especially...
1 wrz 2008 · In postmenopausal women, a 10-mg daily dose of alendronate is effective for secondary (number needed to treat [NNT] = 16) and primary (NNT = 50) prevention of vertebral fractures.
